VAXELIS Trademark Information

Trademark by MSP VACCINE COMPANY

Vaccines used to prevent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b in humans

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: VAXELIS
Status/Status Date:
STATEMENT OF USE - TO EXAMINER
7/20/2021
Serial Number: 88276439
Filing Date: 1/25/2019
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Vaccines used to prevent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b in humans
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 5/21/2019
Last Applicant/Owner:
MSP VACCINE COMPANY
SWIFTWATER, PA 18370
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
MERCK & CO., INC.
126 E. LINCOLN AVENUE
OFFICE OF GENERAL COUNSEL
RAHWAY, NJ 07065
Current Status:
STATEMENT OF USE - TO EXAMINER
7/20/2021
Correspondent Search:
Amy C. Van Eepoel is a correspondent of VAXELIS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on